Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Teva
Chinese Patent Office
Express Scripts
UBS
Cantor Fitzgerald
Harvard Business School
Chubb
Medtronic
Farmers Insurance

Generated: November 21, 2018

DrugPatentWatch Database Preview

Lederle Company Profile

« Back to Dashboard

What is the competitive landscape for LEDERLE, and what generic and branded alternatives to LEDERLE drugs are available?

LEDERLE has ninety-six approved drugs.



Summary for Lederle
US Patents:0
Tradenames:49
Ingredients:48
NDAs:96

Drugs and US Patents for Lederle

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Lederle DIPHENHYDRAMINE HYDROCHLORIDE diphenhydramine hydrochloride ELIXIR;ORAL 086937-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial
Lederle TRIPLE SULFAS trisulfapyrimidines (sulfadiazine;sulfamerazine;sulfamethazine) TABLET;ORAL 006920-002 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial
Lederle LEDERCILLIN VK penicillin v potassium TABLET;ORAL 060134-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial
Lederle PROPRANOLOL HYDROCHLORIDE propranolol hydrochloride TABLET;ORAL 072119-001 Jun 23, 1988 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial
Lederle AMITRIPTYLINE HYDROCHLORIDE amitriptyline hydrochloride TABLET;ORAL 086743-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial
Lederle MINOCIN minocycline hydrochloride INJECTABLE;INJECTION 062139-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial
Lederle CHLORPROMAZINE HYDROCHLORIDE chlorpromazine hydrochloride TABLET;ORAL 084789-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Expired US Patents for Lederle

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Lederle ASENDIN amoxapine TABLET;ORAL 018021-004 Approved Prior to Jan 1, 1982 3,681,357 ➤ Try a Free Trial
Lederle ASENDIN amoxapine TABLET;ORAL 018021-001 Approved Prior to Jan 1, 1982 3,546,226 ➤ Try a Free Trial
Lederle ASENDIN amoxapine TABLET;ORAL 018021-002 Approved Prior to Jan 1, 1982 3,546,226 ➤ Try a Free Trial
Lederle ASENDIN amoxapine TABLET;ORAL 018021-002 Approved Prior to Jan 1, 1982 3,663,696 ➤ Try a Free Trial
Lederle ASENDIN amoxapine TABLET;ORAL 018021-003 Approved Prior to Jan 1, 1982 3,663,696 ➤ Try a Free Trial
Lederle ASENDIN amoxapine TABLET;ORAL 018021-003 Approved Prior to Jan 1, 1982 3,546,226 ➤ Try a Free Trial
Lederle ASENDIN amoxapine TABLET;ORAL 018021-003 Approved Prior to Jan 1, 1982 3,681,357 ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Paragraph IV (Patent) Challenges for LEDERLE drugs
Drugname Dosage Strength Tradename Submissiondate
➤ Subscribe for Oral Suspension 500 mg/5 mL ➤ Subscribe 2014-07-22
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Fish and Richardson
Federal Trade Commission
McKinsey
Citi
Chubb
Medtronic
Cerilliant
US Department of Justice
Cipla

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.